Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast cancer.

[1]  J. Bellon,et al.  Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  L. Norton,et al.  Effect of addition of adjuvant paclitaxel on radiotherapy delivery and locoregional control of node-positive breast cancer: cancer and leukemia group B 9344. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  G. Hortobagyi,et al.  Clinically relevant pneumonitis after sequential paclitaxel-based chemotherapy and radiotherapy in breast cancer patients. , 2004, Journal of the National Cancer Institute.

[4]  C. Freeman,et al.  Delay in adjuvant radiation treatment and outcomes of breast cancer – a review , 2002, Breast Cancer Research and Treatment.

[5]  C. Takimoto,et al.  Dose-intense paclitaxel: deja vu all over again? , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Barbara L. Smith,et al.  Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Richard L Schilsky,et al.  Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  S. Martino,et al.  Breast‐Conserving Therapy with Adjuvant Paclitaxel and Radiation Therapy: Feasibility of Concurrent Treatment , 2003, The breast journal.

[9]  E. Perez,et al.  Preoperative twice-weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer: a phase I/II trial. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  F. Vicini,et al.  Acute and Subacute Toxicity Associated with Concurrent Adjuvant Radiation Therapy and Paclitaxel in Primary Breast Cancer Therapy , 2002, The breast journal.

[11]  J. Verweij,et al.  Comparative pharmacokinetics of unbound paclitaxel during 1- and 3-hour infusions. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  R. Clough,et al.  Technical factors associated with radiation pneumonitis after local +/- regional radiation therapy for breast cancer. , 2002, International journal of radiation oncology, biology, physics.

[13]  A. Niemierko,et al.  Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel. , 2001, Journal of the National Cancer Institute.

[14]  J. Bellon,et al.  Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in high-risk breast cancer. , 2000, International journal of radiation oncology, biology, physics.

[15]  A. Recht,et al.  Concurrent CMF and radiation therapy for early stage breast cancer: results of a pilot study. , 1999, International journal of radiation oncology, biology, physics.

[16]  H. Choy.  Taxanes in combined-modality therapy for solid tumors. , 1999, Oncology.

[17]  P. Viens,et al.  Concomitant chemoradiotherapy for patients with nonmetastatic breast carcinoma , 1999, Cancer.

[18]  L. Milas,et al.  Combination of taxanes with radiation: preclinical studies. , 1999, Seminars in radiation oncology.

[19]  L. Demange,et al.  Sequential or simultaneous chemo-radiotherapy in operable breast cancer. A French multicentric phase III study — State of inclusions , 1998 .

[20]  D. Schultz,et al.  Concurrent chemotherapy and radiation for breast conservation treatment of early-stage breast cancer. , 1998, The cancer journal from Scientific American.

[21]  D. Schultz,et al.  The effects of sequence and type of chemotherapy and radiation therapy on cosmesis and complications after breast conservation therapy. , 1996, International journal of radiation oncology, biology, physics.

[22]  A. Recht,et al.  The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. , 1996, The New England journal of medicine.

[23]  T. Pajak,et al.  Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) , 1995, International journal of radiation oncology, biology, physics.

[24]  T. Buchholz,et al.  Effect of delay in radiation in the combined modality treatment of breast cancer. , 1993, International journal of radiation oncology, biology, physics.

[25]  F. Vicini,et al.  Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage, node-positive breast cancer: sequencing, timing, and outcome. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  F. Vicini,et al.  Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy. , 1991, International journal of radiation oncology, biology, physics.

[27]  F. Vicini,et al.  Cosmetic results after surgery, chemotherapy, and radiation therapy for early breast cancer. , 1991, International journal of radiation oncology, biology, physics.

[28]  Anna L. Brown,et al.  Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowe , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.